Cloud Banner

Healthcare

Image

Global Bone Marrow Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Jan 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Bone Marrow Market, By Transplantation Type (Allogeneic Bone marrow Transplantation, Autologous Bone Marrow Transplantation), Disease Indication (Lymphoma, Leukemia, Myeloma, Myelodysplasia, Aplastic Anemia, Sickle cell Anemia, Solid Tumors, Thalassemia, Myeloproliferative Neoplasms, Others), End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers) – Industry Trends and Forecast to 2031.

Bone Marrow Market

 

Bone Marrow Market Analysis and Size

Major factors that are boosting the growth of the bone marrow market in the forecast period are the growing incidences of non-Hodgkin and Hodgkin lymphoma, thalassemia, and leukemia, along with the common bone marrow diseases around the world, the developments in technology and the enhancing of the healthcare infrastructure. Furthermore, the advancing signs of bone marrow transplant for heart and neuronal disorders, increasing funding for logistic services, and the growing per capita healthcare expenses are some of the other factors anticipated to further propel the growth of the bone marrow market in the coming years. However, the high expenditure for the treatment, shortage of bone marrow donors, and instability of the repayment are a few of the factors further responsible for impeding the growth of the bone marrow market in the near future.

Data Bridge Market Research analyses that the global bone marrow market, which was USD 10, 541.69 million in 2023, would rocket up to USD 15,231.03 million by 2031 and is expected to undergo a CAGR of 5.40% during the forecast period. “Hospitals” dominate the end user segment of the market due to the convenience of consolidated medical services under one roof, streamlining patient care and making IMRT an attractive treatment option there. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Transplantation Type (Allogeneic Bone marrow Transplantation, Autologous Bone Marrow Transplantation), Disease Indication (Lymphoma, Leukemia, Myeloma, Myelodysplasia, Aplastic Anemia, Sickle cell Anemia, Solid Tumors, Thalassemia, Myeloproliferative Neoplasms, Others), End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers)

Countries Covered

U.S., Canada, Mexico, Germany, France, Spain, Turkey, U.K., Netherlands, Russia, Switzerland, Belgium, Hungary, Italy, Rest of Europe, China, India, Japan, Australia, South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Rest of Middle East and Africa

Market Players Covered

Agendia (U.S.), Agilent Technologies, Inc. (U.S.), Ambrilia Biopharma Inc. (U.S.), Astellas Pharma Inc. (U.S.), DiaDexus (U.S.), Illumina, Inc. (U.S.), QIAGEN (U.S.), F Hoffmann-La Roche Ltd (U.S.)Sanofi (France), Stryker Corporation (U.S.),PromoCell GmbH (Germany), STEMCELL Technologies Inc. (Canada), Lonza (U.S.), AllCells (U.S.), ATCC (American Type Culture Collection) (U.S.), Lifeline Cell Technology(U.S.), Conversant Bio (U.S.), HemaCare (U.S.), Mesoblast Ltd. (U.S.), Merck KGaA (Germany), Discovery Life Sciences (U.S.), ReeLabs Pvt. Ltd.  ( India), Gamida Cell (Israel), among others

Market Opportunities

  • Expansion of key players in emerging countries
  • Increasing research and development activities for bone marrow transplant

Market Definition

Bone marrow transplant also referred to as hematopoietic stem cell. It is a soft vascular tissue present in the interior of long bones. It comprises of two types of stem cells that are hematopoietic and mesenchymal stem cells. Bone marrow is mainly responsible for the haematopoiesis, (formation of blood cells), production of lymphocytes, and the storage of fats. The bone marrow transplant is the last alternative generally recommended by the physicians in the cases of fatal bone marrow diseases and bone or skin cancer.

Global Bone Marrow Market Dynamics

Drivers

  • Increasing Incidence of blood disorders

The rising prevalence of blood-related disorders such as leukemia, lymphoma, and other haematological diseases is a significant driver for the bone marrow transplant market. For instance, according to data provided by the American Cancer Society, Inc., a voluntary health organization dedicated to eliminating cancer, it is estimated that about 80,470 people (44,120 males and 36,350 females) will be diagnosed with NHL in 2022 in the U.S., this includes both adults and children.

  • Rising geriatric population

The aging population is more prone to conditions that may require bone marrow transplants, leading to an increased demand for these procedures. The rising cancer incidence and population ageing are two of the most important factors driving market growth. Furthermore, the elderly are more vulnerable to diseases, and life expectancy in developing countries has surpassed 80 years.

  • Increasing research and development activities for bone marrow transplant

Chemotherapy or radiation suppresses the immune system and puts patients at high risk of infections, organ damage, and other life-threatening side effects. The method developed by the researchers at Washington University School of Medicine in St. Louis, U.S., takes an immunotherapeutic approach, combining the targeted elimination of blood-forming stem cells in the bone marrow with immune-modulating drugs to prevent the immune system from rejecting the new donor stem cells. This method could eliminate dangerously low blood cell counts, bleeding complications, organ damage, and infections. Thus, the market for bone marrow is being driven by a number of factors, including the adoption of bone marrow transplant which is growing in emerging markets due to increased healthcare spending and the expansion of healthcare infrastructure.

Opportunity

  • Increasing technological advancements in bone marrow therapy to improve treatment

Advances in transplant technologies and techniques contribute to the growth of the market. Improvements in conditioning regimens, donor selection, and supportive care have enhanced the success rates of bone marrow transplants.

Moreover, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart disorders, growing investment in logistic services are expected to increase, which in turn, will create lucrative market growth opportunities.

Restraint/Challenge

  • High cost of treatment 

The high cost of treatment is expected to restraint the market. Bone marrow transplant procedures can be expensive, including pre-transplant conditioning, the transplant itself, and post-transplant care. The high cost may limit access to these treatments for some patients. Moreover, bone marrow transplant procedures come with inherent risks, including infections, graft-versus-host disease, and other complications. The potential for adverse events may discourage some patients from pursuing transplantation that can be simply is projected to challenge the bone marrow market in the forecast period of 2024-2031.

This bone marrow market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone marrow market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In September 2022 Scopio Labs launched the Full-Field Bone Marrow Aspirate (FF-BMA) application, which enables a complete digital workflow for bone marrow aspirate scanning and analysis
  • In June 2022, The US FDA 510(k) approval was granted to launch MAXX-BMC in the United States, which Royal Biologics manufactures. MAXX-BMC is a bone marrow aspirate concentration system that provides users with an optimal sample of concentrated bone marrow aspirate from a patient at the point of care

Global Bone Marrow Market Scope

The bone marrow market is segmented on the basis of transplantation type, disease indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Transplantation Type

  • Allogeneic Bone marrow Transplantation
  • Autologous Bone Marrow Transplantation

Disease Indication

  • Lymphoma
  • Leukemia
  • Myeloma
  • Myelodysplasia
  • Aplastic Anemia
  • Sickle cell Anemia
  • Solid Tumors
  • Thalassemia
  • Myeloproliferative Neoplasms
  • Others

End User

  • Hospitals
  • Multi-Specialty Clinics
  • Ambulatory Surgical Centers

Global Bone Marrow Market Regional Analysis/Insights

The bone marrow market is analyzed and market size insights and trends are provided by country, transplantation type, disease indication, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and rest of Middle East and Africa.

Europe is expected to dominate the market because of the occurrence of the increasing number of innovative healthcare centers. Furthermore, the healthcare systems have introduced bone marrow transplants in their contributions and state-of-the-art public facilities, which will further boost the growth of the bone marrow market in the region during the forecast period.

North America is expected to witness significant growth during the forecast period of 2024 to 2031 due to the growing cases of chronic diseases such as blood cancer. Moreover, the increasing geriatric population is one of the factors anticipated to propel the growth of the bone marrow market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Bone Marrow Market Share Analysis

The bone marrow market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone marrow market.

Some of the major players operating in the bone marrow market are:

  • Agendia (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Ambrilia Biopharma Inc. (U.S.)
  • Astellas Pharma Inc. (U.S.)
  • DiaDexus (U.S.)
  • Illumina, Inc. (U.S.)
  • QIAGEN (U.S.)
  • F Hoffmann-La Roche Ltd (U.S.)
  • Sanofi (France)
  • Stryker Corporation (U.S.)
  • PromoCell GmbH (Germany)
  • STEMCELL Technologies Inc. (Canada)
  • Lonza (U.S.)
  • AllCells (U.S.)
  • ATCC (American Type Culture Collection) (U.S.)
  • Lifeline Cell Technology (U.S.)
  • Conversant Bio (U.S.)
  • HemaCare (U.S.)
  • Mesoblast Ltd. (U.S.)
  • Merck KGaA (Germany)
  • Discovery Life Sciences (U.S.)
  • ReeLabs Pvt. Ltd.  (India)
  • Gamida Cell (Israel)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The bone marrow market size will be worth USD 15,231.03 million by 2031 during the forecast period.
The growth rate of the bone marrow market is 5.40% during the forecast by 2031.
The Increasing Incidence of blood disorders & Rising geriatric population are the growth drivers of the bone marrow market.
The Transplantation type, disease indication, and end-user are the factors on which the bone marrow market research is based.
The Major companies in the bone marrow market are Agendia (U.S.), Agilent Technologies, Inc. (U.S.), Ambrilia Biopharma Inc. (U.S.), Astellas Pharma Inc. (U.S.), DiaDexus (U.S.), Illumina, Inc. (U.S.), QIAGEN (U.S.), F Hoffmann-La Roche Ltd (U.S.)Sanofi (France), Stryker Corporation (U.S.),PromoCell GmbH (Germany), STEMCELL Technologies Inc. (Canada), Lonza (U.S.), AllCells (U.S.), ATCC (American Type Culture Collection) (U.S.), Lifeline Cell Technology(U.S.), Conversant Bio (U.S.), HemaCare (U.S.), Mesoblast Ltd. (U.S.), Merck KGaA (Germany), Discovery Life Sciences (U.S.), ReeLabs Pvt. Ltd. ( India), Gamida Cell (Israel).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials